Chemoinformaics analysis of Hydroxysanguinarine
| Molecular Weight | 347.326 | nRot | 0 |
| Heavy Atom Molecular Weight | 334.222 | nRig | 6 |
| Exact Molecular Weight | 347.079 | nRing | 6 |
| Solubility: LogS | -2.581 | nHRing | 3 |
| Solubility: LogP | 2.822 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 3 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 21 |
| nHA | 6 | APOL | 47.1783 |
| nHD | 0 | BPOL | 22.5637 |
| QED | 0.461 |
| Synth | 2.729 |
| Natural Product Likeliness | 2.02 |
| NR-PPAR-gamma | 0.947 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.936 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.45 |
| MDCK | 0.0000454 |
| BBB | 0.961 |
| PPB | 0.854177 |
| VDSS | 0.65 |
| FU | 0.189248 |
| CYP1A2-inh | 0.211 |
| CYP1A2-sub | 0.214 |
| CYP2c19-inh | 0.068 |
| CYP2c19-sub | 0.39 |
| CYP2c9-inh | 0.03 |
| CYP2c9-sub | 0.875 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.383 |
| CYP3a4-inh | 0.123 |
| CYP3a4-sub | 0.226 |
| CL | 9.284 |
| T12 | 0.726 |
| hERG | 0.017 |
| Ames | 0.03 |
| ROA | 0.016 |
| SkinSen | 0.922 |
| Carcinogencity | 0.733 |
| EI | 0.912 |
| Respiratory | 0.122 |
| NR-Aromatase | 0.017 |
| Antiviral | Yes |
| Prediction | 0.715115 |